Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Febuxostat 80 mg vs Feburic 80 mg Under Fasting in Healthy Thai Volunteers
TCTR20250326005Phase 2Unknown
- Sponsor
- International Bio Service
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in hyperuricemia, gout, sponsored by International Bio Service. Status: unknown.
02
Drugs
febuxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on TCTR20250326005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250326005.